• Overview of some incremental learning algorithms more
  • Overview of some incremental learning algorithms more
  • Overview of the Therapeutic Use of Medicines in Mental Health more
  • Overweight and obesity in children: A review of the literature more
  • Overweight children and adolescents [5] (multiple letters) more
  • Overweight children and adolescents. more
  • Overweight, obesity and the food service industry more
  • Overweight, obesity and the food service industry more
  • Own- and other-race face learning in high and low variability more
  • Owner Occupied Housing Taxation: A Vertical Equity Evaluation of the UK and US Tax Systems. In Salter and Oats ed Contemporary Issues in Tax Research more
  • Owner Occupied Housing Taxation: An Equity Evaluation of the UK and US Tax Systems more
  • Owner Occupied Housing Taxation: an Extension of a Classical Structural Measure of Vertical Equity more
  • Owner Occupied Housing Taxation: Challenging Conventional Wisdoms more
  • Owner-Managers and the Failure of Newly Adopted Work Councils more
  • Owner-occupied housing taxation: an equity evaluation of the UK and US tax systems. more
  • Ownership Structure, Corruption, and Capital Investment: Evidence from Firms in Selected Sub-Saharan African Countries more
  • Ownership, Activism and Engagement: Institutional Investors as Active Owners more
  • Ownership, risk and efficiency in the banking sector of the ASEAN countries more
  • Owning Form, Sharing Content: Natural-Right Copyright in the Digital Environment more
  • OX40- and CD27-Mediated costimulation synergizes with Anti-PD-L1 blockade by forcing exhausted CD8+ T cells to exit quiescence more
  • Oxaliplatin in colon cancer [3] (multiple letters) more
  • Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer more
  • Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial. more
  • Oxaliplatin/5FU/LV in stage II and III Colon Cancer: Updated results (as of January 04) for efficacy and neurotoxicity of the MOSAIC trial more
  • Oxaliplatin/5FU/LV in the adjuvant treatment of stage II and stage III colon cancer:: Efficacy results with a median follow-up of 4 years. more

Previous Next